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ABSTRACT 
 
Background:  Dehydroepiandrosterone  (DHEA)  is  a  steroid  hormone  secreted  by  the  adrenal  cortex. 
Recent research reports show that DHEA has various beneficial effects including neuro protective effects 
and that the decline in its production with aging may contribute to neuronal dysfunction and degeneration, 
and thus cognitive decline.Aim: To assess the cognitive functions and estimate the levels of DHEA in 
subjects of the same age group. Materials and Methods: A cross sectional comparative study of sixty 
healthy male participants between 60 to 70 years of age was done. They did not have other medical 
disorders likely to affect cognitive function. Their performance in the principal domains of cognition, i.e. 
memory, attention and concentration, verbal fluency, language and visuospatial functioning was observed. 
Serum levels of DHEA were estimated for all the participants by ELISA method. Results: A significant 
positive correlation was observed between DHEA level and three domains of cognition viz., visuospatial 
skills (r = 0.95), verbal fluency (r = 0.49) and short term memory (r = 0.28). No association was found 
with other domains of cognition. Conclusion: Subjects with low levels of serum DHEA among the same 
age group showed a significant decline in visuospatial skills, short term memory and verbal fluency.  
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INTRODUCTION 
Dehydroepiandrosterone  (DHEA)  is  a  steroid, 
mainly of adrenal origin, that is found in relatively 
high concentrations in human plasma. It serves as 
a  precursor  of  both  androgenic  and  estrogenic 
steroid hormones. In the circulation, DHEA exists 
both free and bound to sulphate (DHEA-S). Thus, 
DHEA-S serves as the principal storage form of 
DHEA. DHEAS – has many intrinsic effects like 
antiaging,  antiobesity,  antidiabetic,  anti 
atherogenic  and  neuroprotective  effects
1.  A 
progressive  decrease  in  circulating  levels  of 
DHEA with age has long been recognized, with 
peak levels occurring between the third and fourth 
decades  of  life  and  decreasing  progressively 
thereafter  by  about  90%  over  the  age  of  85. 
Though DHEAS levels peak at around 25 years of 
age and starts declining with increase in age, it is 
subject  to  wide  inter-individual  variations.  Its 
levels  are  also  affected  by  factors  like  gender, 
physical activity etc. Recent research reports show 
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that decline in DHEA production with aging may 
contribute  to  neuronal  dysfunction  and 
degeneration, and thus cognitive decline. Animal 
experiments  showed  that  DHEAS  can  enhance 
neuronal and glial survival and differentiation in 
culture
2,  3.  Administration  of  DHEA  has  been 
reported  to  have  striking  beneficial  effects  on 
memory.  Their  cognitive  performances  were 
directly  related  to  increases  in plasma  levels  of 
DHEA and DHEA-S
4. The present study thus was 
performed  to  investigate  possible  associations 
between DHEA levels and cognitive performance 
in healthy elderly men. 
MATERIALS AND METHODS 
, 
After the institutional ethical approval the present 
study was conducted in the Institute of Physiology 
and  Experimental  medicine,  Madras  Medical 
College,  Chennai.  After  obtaining  informed 
consent,  sixty  healthy  male  subjects  (who  had 
completed  at  least  10  years  of  basic  school 
education)  aged  between  60  and 70  years  were 
selected randomly from the urban population of 
Chennai  city.  They  did  not  have  other  medical 
disorders likely to affect cognitive function. We 
explained the scope and details of the study to the 
subjects. The subjects underwent routine clinical 
examination and biochemical tests to satisfy the 
selection criteria. . Fasting blood samples of the 
subjects were obtained for estimation of DHEA-S. 
Fasting blood samples were obtained under strict 
aseptic  precautions,  by  venepuncture  of  the 
antecubital  vein.  The  serum  was  separated  and 
stored in the deep freezer at -20
0 C. The serum 
levels  of  DHEA-S  was  measured  using  ELISA 
kits viz. serum Dehydroepiandrosterone sulphate 
estimation  supplied  by  Cal  biotech  Inc 
(California).  The  Addenbrooke's  Cognitive 
Examination- Revised (ACE-R) 
16 was applied to 
all  the  participants.  It  is  a  brief  and  simple 
cognitive  screening  tool.  It  is  established  as  a 
sensitive  screening  test  for  Mild  Cognitive 
Impairment, dementia and Alzheimer’s disease. It 
takes about 15 minutes to administer this test for 
each participant.  
 
   
Table: 1. ACE-R five major domains of cognition and normal values. 
  Normal Values             Below normal/poor 
Attention                                      16 and above  <16 
Memory  17 and above  <17 
Verbal fluency                                 9 and above  <9 
Language     22 and above  <22 
Visuospatial functioning                14 and above  <14 
 
RESULTS 
In our study the mean DHEA level (µg/dl) of the 
subjects  was  (142.9  ±  36).  We  observed  a 
significant  positive  correlation  between  DHEA 
level  and  three  domains  of  cognition  viz., 
visuospatial skills (r = 0.95), verbal fluency (r = 
0.49)  and  short  term  memory  (r  =  0.28).  No 
significant  association  was  found  with  other 
domains of cognition 
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Fig:1.Correlation between DHEA (µg/dl) and verbal fluency.  
 
Fig:2.Correlation between DHEA (µg/dl) and visuospatial skills.  
 
Fig:3. Correlation between DHEA (µg/dl) and short term memory.  
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Table: 2. Correlation between DHEA and Visuospatial skills
 
Table: 3. Correlation between DHEA and Short Term Memory. 
 
Table: 4. Correlation between DHEA and Verbal Fluency 
 
Table 5: Correlation between DHEA and Long Term Memory. 
 
      No significant correlation 
Table 6: Correlation between DHEA and Language skills. 
 
        No significant correlation 
1.000 .952**
.952** 1.000
. .000
.000 .
60 60
60 60
DHEA
VISUOSPA
DHEA
VISUOSPA
DHEA
VISUOSPA
Pearson
Correlation
Sig.
(2-tailed)
N
DHEA VISUOSPA
Correlation is significant at the 0.01 level **. 
1.000 .279*
.279* 1.000
. .031
.031 .
60 60
60 60
DHEA
STM
DHEA
STM
DHEA
STM
Pearson
Correlation
Sig.
(2-tailed)
N
DHEA STM
Correlation is significant at the 0.05 level *. 
1.000 .487**
.487** 1.000
. .000
.000 .
60 60
60 60
DHEA
FLUEN
DHEA
FLUEN
DHEA
FLUEN
Pearson
Correlation
Sig.
(2-tailed)
N
DHEA FLUEN
Correlation is significant at the 0.01 level **. 
1.000 .059
.059 1.000
. .655
.655 .
60 60
60 60
DHEA
LTM
DHEA
LTM
DHEA
LTM
Pearson
Correlation
Sig.
(2-tailed)
N
DHEA LTM
1.000 .068
.068 1.000
. .604
.604 .
60 60
60 60
DHEA
LANG
DHEA
LANG
DHEA
LANG
Pearson
Correlation
Sig.
(2-tailed)
N
DHEA LANG
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DISCUSSION 
Debonnel  et  al  in  the  year  1996  showed  that 
DHEA  acts  on  the  central  nervous  system  to 
increase  the  effects  of  the  excitatory 
neurotransmitter,  glutamate,  and  decrease  the 
effects of the inhibitory neurotransmitter, GABA
5. 
DHEA  and  its  sulfated  form  are  considered 
neuroactive  because  they  affect  the  GABA-A 
receptor complex and NMDA-mediated glutamate 
transmission via sigma receptors
12. Studies have 
also  shown  that  DHEA  increases  neuronal 
excitability, enhances neuronal plasticity and acts 
as a neuroprotective agent 
6.  
Blauer  et  al  in  1991observed  that  both  the 
immunological  and  neural  effects  of  DHEA/S 
may  be  related  to  their  powerful 
antiglucocorticoid action 
7.  It has been proved that 
very high levels of cortisol can cause damage to 
neurons,  particularly  in  the  hippocampus
8.  The 
adverse effects of cortisol  which might be seen 
during stress or trauma may be counteracted by 
the high levels of DHEA. Lower levels of DHEA 
in older adults may make them more vulnerable to 
the damaging effects of cortisol
9. In vitro studies 
have  proved  that  DHEA  can  increase  the 
proliferation of human neural stem cells and the 
number of neurons.  
Some  research  studies  showed  lower  levels  of 
DHEA  in  the  serum of  patients  diagnosed  with 
dementia
10. DHEA and DHEA sulfate are proved 
to be  neurosteroids  that  modulates  learning  and 
memory
11.  
Wolf et al in 1997 found significant improvement 
following  DHEA  administration  compared  with 
placebo  in  both  immediate  recall  and  delayed 
recall memory test
13. Higher endogenous DHEAS 
levels  were  independently  and  favorably 
associated  with  better  executive  function, 
concentration,  and  working  memory
15.  Cross-
sectional  studies  have  reported  a  relationship 
between  the  prevalence  of  Alzheimer’s  disease 
and  low  dehydroepiandrosterone  sulphate 
(DHEA-S) plasma levels
14.  
CONCLUSION 
In an aim to find an association between DHEA 
levels and cognitive functions in healthy ageing, 
we found that higher levels of DHEA was linked 
to  better  visuospatial  skills,  verbal  fluency  and 
short  term  memory.  Recently,  there  has  been  a 
resurgence  of  interest  in  DHEA,  because  it  has 
been  suggested  that  it  might  have  anti-ageing 
effects.  It  has  also  been  suggested  that  serum 
DHEA  may  be  represented  as  a  biomarker  of 
healthy  aging  and  physiological  methods  of 
improving its levels by physical activity, diet etc., 
are topics of recent research. Hence, age related 
cognitive  decline,  Alzheimer’s  disease  and  its 
associated complications which are considered as 
an expanded spectrum of accelerated ageing can 
attribute  a  part  of  its  pathogenesis  to  lowering 
DHEA levels. Further research on this topic can 
derive clues to pathogenesis of ageing. 
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